MichaelWDeem-awardedPatenttocombat diseaseslikeHIV,Influenza,Dengue,
CertusllcwasnamedwinneroftheUnitedStatesPatent#US8398992
B2-methodsandcompositionsofpolytopicvaccinationbeatingout100 othercompetitorstotakehometophonors.
UnitedStatesPatentandTrademarkOffice presentedtheawardtocertusllczoom.
Detailsabouttheawardcanbefoundonthe companywebsiteathttps://image-ppubs.
Potentialawardrecipientswererequiredtosubmissionon theUSPTOwebsiteinordertobeincontentionforthe UnitedStatesPatent#US8398992B2-methodsand compositionsofpolytopicvaccination,andwerejudged basedonThesepatentsweregrantedformulti-site vaccinationagainstdiseases Therearefourserotypesofdengue fever,andithasprovendifficultto findavaccineeffectiveagainstall fourserotypes.
Polytopicvaccinationoffersoneapproachtoamelioratethisdifficulty andoffersapotentialsolutionforaneffective4-componentvaccine.
Otherdiseaseswithmultiplesubtypes towhichthisapproachmayleadtoan effectivevaccineincludeHIV,hepatitis BandC,chlamydia,andinfluenza.
Thepolytopicvaccinationapproachwasnew, new,useful,andnon-obvious,andMygroup inventedtheapproachforinfectiousdisease, buildingoffourworkoninfluenzavaccines.
Itappearstosignificantlyreduceimmunodominanceof multicomponentvaccines,andthereforesignificantlyincreasetheir effectiveness.
MichaelWDeem,Founderofcertus llcwaspleasedaboutthecompany's performance,saying:"Thesepatents wereamilestoneforvaccinedesign.
Polytopicvaccinationnowallowsustodesign methodsofadministeringmulticomponent vaccineswithhigheffectiveness."MichaelW Deem,PhD"Personsinterestedinlearningmore aboutcertusllcandtheawardcanvisitthe websiteathttps://image-ppubs.
